Chimeric antigen receptor (CAR) T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, ...
Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.
A new study conducted at the Scojen Institute for Synthetic Biology at Reichman University’s Dina Recanati School of Medicine announces the launch of the ChiTaRS 8.0 database, the world’s largest ...
Researchers developed a chimeric cancer drug that links an Aurora kinase A inhibitor to a tumor-targeting molecule. In ...
The proteins that allow viruses to land on bacteria — Gp38 — are attracted to FadL and OmpF, two proteins that help make up the outer walls of bacterial cells. StfE2, the chimeric protein formed with ...
Julia Darby’s tagged chimeric proteins told a convincing story. Later, she learned that they distorted some of the details. When I expressed the different protein constructs in neuron cells in culture ...
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis The following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results